APA

Durrant K. R., Mangioni C., Lacave A. J., George M., van der Burg M. E., Guthrie D., Rotmenz N., Dalesio O. & Vermorken J. B. (19900713). Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). : Gynecologic oncology.

Chicago

Durrant K R, Mangioni C, Lacave A J, George M, van der Burg M E, Guthrie D, Rotmenz N, Dalesio O and Vermorken J B. 19900713. Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). : Gynecologic oncology.

Harvard

Durrant K. R., Mangioni C., Lacave A. J., George M., van der Burg M. E., Guthrie D., Rotmenz N., Dalesio O. and Vermorken J. B. (19900713). Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). : Gynecologic oncology.

MLA

Durrant K R, Mangioni C, Lacave A J, George M, van der Burg M E, Guthrie D, Rotmenz N, Dalesio O and Vermorken J B. Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). : Gynecologic oncology. 19900713.